Professors of oriental medicine prescription. Oriental medicine prescription. Seoul:Youngrimsa. 2003:78-9.

Kim JD, Kang YG. National Health Insurance Statistical Yearbook. Seoul:National Health Insurance Corporation, Health Insurance Review & Assessment Service. 2010:300-1.

Park YH, Huang DS, Shin HK. The Analysis of Herbal Medicine Preparations Equipped in Traditional Korean Medical Clinics. The Kor. J. Oriental Medical Pres. 2010;18(1):43-56.

永井隆之, 山田陽城. 気管支喘息モデルマウスの 気道免疫系に対する小青龍湯の影響. The gen eral meeting of Medical and Pharmaceutical Society for Wakan-yaku. 1998;15:47.

童舜華, 吳敦序, 包照日格圖, 陳淑俊, 溪蓓莉. 小青龍湯對大鼠哮喘模型肺组織糖皮質激素受体的 影響. 中成藥. 1998;20(6):32-4.

Cho YM, Jung HJ, Jung SK, Rhee HK. The effects of Sochungryong-tang on the respiratory patterns and tracheal tissues in allergic asthma. K.H.M. 1999;15(1):78-89.

Tong SH. Ef fects of Minor Green-Blue Dragon Decoction And Bushendingchuan Decoction on Pulmonary Tissue AR and cAMP Levels of Rat with Asthma. Chinese Traditional Patent Medicine. 1999;21(6):304-6.

童舜華, 吳敦序, 包照日格圖, 陳淑俊, 溪蓓莉. 小青龍湯對大鼠哮喘模型肺组織糖皮質激素受体和-受体等水平的影響. 中国中医基础医學雜誌. 1999; 5(3):18-21.

Tong SH, Wu DX, Chen SJ, Shi XL. Effect of Xiaoqinglongtang on airway resistence, pulmonary dynamic compliance and eosinophil in rat with asthma. Chinese Journal of Traditional Medical Science and Technology. 1999;6(2): 79-80.

Rhee JW, Jung HJ, Jung SK, Rhee HK. The effects of Socheongryong-Tang on lymphocytes in BALF of rat. K.H.M. 2001;17(2):242-53.

荒井 裕美子, 永井 隆之, 矢部武士, 竹田 忠紘, 山田 陽城. 小青龍湯の肺NGF産生を介した気管支喘息モデルマウスに対する効果の検討. 和漢医藥學會. 2001;18:107.

王光利. 小青龍湯治療哮喘藥理机制探討. 臨床急診雜誌. 2001;2(2):56-8.

Tong SH, Cui YL, Xu JH. Study on the effect of Xiaoqinglong decoction of pulmonary tissues 2 AR level of rat with asthma. Chinese Journal of Traditional Medical Science and Technology. 2001;8(2):77-9.

Kao ST, Lin CS, Hsieh CC, Hsieh WT, Lin JG. Effects of xiao-qing-long-tang (XQLT) on bronchoconstriction and airway eosinophil infiltration in ovalbumin-sensitized guinea pigs: in vivo and in vitro studies. Allergy. 2001:56:1164-71.

Wang L, Liu FZ, Gao H, Shang SC, Tian JH. Effect of Xiaoqinglong decoction (小青龙汤) on ET-1 and NO from the asthmatic rat. Pharmacology and Clinics of Chinese Materia Medica. 2002;18(5):7-9.

倪力强, 张宁霞, 童瑶, 陈慧娟. 小青龍湯對哮喘大鼠Th1/Th2型细胞因子水平的影響. 遼宁中医雜志. 2003;30(9):703-4.

Zhang ZQ, Lian R, Huang JM,, Tian W, Chen DP. Experimental study of Xiaoqinglong decoction( 小青龙汤) on Th1/Th2 balance in the lungs of mice models of asthma. Chin J TCM WM Crit Care. 2004;11(6):368-71.

惠萍, 薛漢榮, 范發才, 鐘春红, 付向春. 小青龍湯与表面激素吸入對哮喘大鼠气道结构重建作用的實驗研究. 新中医, 2006;38(12):84-6.

Kim HW. Effects of Socheongryong-tang on inflammatory cells in asthmatic mice. Kor J Oriental Preventive Medical Society. 2006;10(2): 121-9.

Xue HR, Hong GX, Cheng GY, Fu XC, Lan ZH, Wang LH, et al. Effects of Small Qinglong Decoction medicine-containing serum on ASMC proliferation action Induced by ET-1. China Journal of Traditional Chinese Medicine and Pharmacy. 2006;21(10):594-6.

薛漢榮, 洪广祥, 付向春, 程光宇, 蘭智慧, 王麗華, et al. 小青龍湯含藥血清對ASMC ET-1分泌水平和 ECE基因表達的影响. 中医藥通報. 2006;5(4):56-9.

薛漢榮, 惠萍, 洪广祥, 程光宇, 付向春, 蘭智慧, et al. 小青龍湯對哮喘大鼠气道结构重建的影響. 中医藥通報. 2006;5(3):57-9.

Kim HW. Combination treatment with Socheongryong-Tang, a herbal medicine, and Prednisolone reduces inflammation and hyper responsiveness of the airway in asthmatic mice : via regulation of Th2 skewing cytokines and antigen specific antibody production. Naju (Jeonnam): Dongshin Univ.; 2007.

Jung S, Cho SJ, Moon KI, Kim HW, Kim BY, Cho SI. Effects of Socheongryong-tang on immunoglobulin production in asthmatic mice. Kor J Herbology. 2008;23(1):23-8.

Li JH, Li J, Wu CR, Chen IL, Jiang X. Effect of Xiaoqinglong decoction on expression of NGF in lung and thymus in asthmatic guinea pigs. Journal of TCM Univ. of Hunan. 2008;28(5): 30-2.

Nagai T, Nakao M, Shimizu Y, Kodera Y, Oh-Ishi M, Maeda T, et al. Proteomic Analysis of anti-inflammatory effects of a Kampo (Japanese herbal) medicine 'Shoseiryuto (Xiao-Qing-Long-Tang)' on airway inflammation in a mouse model. eCAM. 2009:1-14.

陈红霞, 周兆山. 小青龙汤、射干麻黄汤及其合方 对大鼠哮喘模型肺泡灌洗液IL-4/INF-影响的实 验研究. 吉林中医药. 2010;30(4):360-1.

Tian HY, Zhou ZS, Yan YX, Chen HX. Study on the Effects of Xiaoqinglong Decoction, Shegan Mahuang Decoction and Their Combined Use on Serum IL-4/INF-in Rat Asthma Model. Progress in Modern Biomedicine. 2010;10(2):248-51.

Luo DD, Qiu ZW. Effect of Xiaoqinglong decoction on airway inflammation and cytokine in a mouse asthmatic model. Progress in Modern Biomedicine. 2010;10(4):655-7.

殷彬, 周兆山, 胡海波, 杨晓萍, 王平丽. 小青龍湯、射干麻黄湯及其合方對哮喘模型大鼠血清 IL-5 及IL-13 的影響. 山東中医雜志. 2011;30(5): 337-9.

Yu JW, Xue HR, Fu XC. Research on Xiaoqinglong decoction to intervene the proliferative effect of airway smooth muscle cells in the rat asthma model. Journal of Sichuan of Traditional Chinese Medicine. 2011;26(4):23-5.

Mo BW, Su HY, Wei JH, Huang JW, Wang CM, Zeng JR, et al. Effect of TLR4 and p-Akt on asthmatic airway smooth muscle migration and the impact of Xiaoqinglong decoction on the migration. Chinese Pharmacological Bulletin. 2011;27(5):723-8.

千代谷厚, 玉置淳, 山内富美子, 武山廉, 兼村俊範, 金野公郎. 気道上皮細胞の電気的特性に対する小青竜湯の影響. アレルギー. 1992;41(8):1233.

黄堅, 陳長勋, 李儀奎. 用血清實驗法觀察小青龍湯對离体豚鼠气管平滑肌的作用. 中藥藥理与臨床. 1995;6:12-3.

Kao ST, Wang SD, Wang JY, Yu CK, Lei HY. The effect of Chinese herbal medicine, xiao-qing-long tang (XQLT), on allergen-induced bronchial inflammation in mite-sensitized mice. Allergy. 2000:55:11207-33.      

永井隆之, 荒井裕美子, 江森道子, 布目慎勇, 矢部 武士, 山田陽城. 気道炎症モデルマウスに対す る神経成長因子を介した小青竜湯の作用機序の 検討. 和漢医藥學會. 2002;19:111.

Na DG, Lee CJ, Park YC. Effects of Socheongryong-tang and Kamichihyo-san on mucin secrection from airway goblet. Korean J Oriental Physiology & Pathology. 2004;18(3): 734-9.

Park IG, Sim SY, Byun HS, Kim KJ. Effects of Sochungyong-tang on cytokine gene expression in mouse alveolar macrophage. The Journal of Korean Oriental Medical Ophthalmology & Otolaryngology & Dermatology. 2005;18(3): 1-17.

梅彤, 張偉, 張心月, 邵雨萌. 小青龍湯對慢性阻塞 性肺疾病大鼠细胞因子水平的影. 云南中醫中藥 雜志. 2006;27(3):54-5.

张伟, 李刚, 张心月, 邵雨萌.小青龍湯對慢性阻塞 性肺疾病大鼠核因子B和-谷氨 半胱氨酸合酶 表达的干预作用. 浙江中医药大學學報. 2006;30(5): 457-60.

Kim JM, Lee CJ, Park YC. Studies on the effect of selected oriental herbal mediciens on inhibitory activity of airway mucus secretion. Korean J Oriental Int Med. 2006;27(1):126-37.

清水ユリ子, 永井隆之, 清原寛章, 白畑辰弥, 砂塚 敏明, 大村智, et al. 小青竜湯の気道炎症に対す る作用及びインフルエンザワクチンに対するア ジュバント活性の検討. 和漢医薬學會. 2007;24:

Yang CQ, Sun PY, Li TZ, Ding DZ, Irie T. Preventive effect of Xiao-qing-long-tang on the hypoxemia induced by oleic acid in guinea-pigs. Chin Hosp Pharm J. 2008;28(3):172-5.

王焱, 于志瀛. 中藥小青龍湯對慢性阻塞性肺疾病 大鼠血清IL-4,IL-8,TNF-水平的影響. 科技资訊. 2009;30:183-4.

Yang CQ, Sun PY, Ding DZ, Moriuchi H, Ishitsuka Y, Irikura M, et al. The ethical Kampo formulation Sho-Seiryu-To (TJ-19) prevents bleomycin-induced pulmonary fibrosis in rats. Biol Pharm Bull. 2010;33(8):1438-42.      

Lee JG, Yang SY, Kim MH, Namgung U, Park YC. Protective effects of Socheongryong-tang on elastase-induced lung injury. J Korean Oriental Med. 2011;32(4):83-99.

栗山一夫, 馬場 廣太郎, 古内一郎, 竹内 良夫. 鼻アレルギーに対する和漢薬 小青竜湯 効果の 基礎的検討(抗アレルギー剤). アレルギー. 1981; 30(8):640.

竹内 良夫, 西村 葉子, 八木 和郎, 吉河 達祐, 木村 義民, 栗山一夫. 和漢薬 小青竜湯 の抗アレ ルギー作用に関する基礎的検討(抗アレルギー 剤). アレルギー. 1982;31(8):599.

Johji Y, Toshio Y, Hitoshi K, Tokunosuke S, Hajime F. Biologically active principles of crude drugs. Anti-allergic principles of "Shoseiryu-to. "I. Effect on delayed-type allergy reaction. Journal of the Pharmaceutical Society of Japan. 1982;102(9):881-6.

竹内 良夫, 西村 葉子, 雑賀 寿和, 栗山 純一, 木村 義民. 既製抗アレルギー剤と和漢薬小青竜湯の 効果比較について. アレルギー. 1984;33(9):748.

竹内良夫, 西村葉子, 吉河達祐, 栗山純一, 木村 義民, 雑賀寿和. 和漢薬 小青竜湯 の抗アレ ルギー作用特に既製抗アレルギー剤との比較. アレルギー. 1985;34(6):387-93.

竹内 良夫, 木村 義民. アレルギー反応における 小青竜湯の薬理作用(<パネルディスカッショ ン>II 和漢薬の抗アレルギー作用機序). アレル ギー. 1986;35(8):622.

曾根 秀子, 川村 秀樹, 丸山 博文, 武元 則人, 小松 靖弘, 油田 正樹, et al. モルットの摘出肺切片標 本を用いた小青竜湯エキスの抗アレルギー作用 機序の研究. アレルギー. 1987;36(8):720.

西澤芳男. 小青竜湯の抗アレルギー作用の検討. アレルギー. 1990;39(9):1174.

Kwon OG, Kwon YK, Kim KJ. An experimental study on sustaining effects and tolerance status of herb medicine -Centering around anti-allergy action experiment of Sochungryongtang and Ounchuneum-. The Journal of Jeahan Oriental Medical Academy. 1995;1(1):49-64.

田中宏幸, 竹田博史, 高岡優子, 稲垣直樹, 永井 博弌. 小青龍湯の実験的アレルギー性皮膚反応 および鼻炎の遅発相に及ぼす影響. The general meeting of Medical and Pharmaceutical Society for Wakan-yaku. 1997;14:98.

Sakaguchi M, Mase A, Iizuka A, Yuzurihara M, Ishige A, Amagaya S, et al. Further pharmacological study on Sho-seiryu-to as an antiallergic. Methods Find Exp Clin Pharmacol. 1997;19(10): 707-13.

李儀奎, 吳健宇, 吳晓芬, 符胜光. 小青龍湯藥物血清對致敏大鼠腹腔肥大细胞脱颗粒以及组织胺释 放的影响. 中国中西医结合雜志. 2000;20(1):40-2.

Nagai H, Takeda H, Nishiyori T, Ochi T, Sawada M, Kato T, et al. Effects of Sho-seiryu-to (Xiao-Qing-Long-Tang) on experimental allergic reactions. Journal of traditional medicines. 2000;17(2):49-58.

田 孔己, 石 毛敦, 佐々木博. 小青竜湯の抗アレ ルギー作用. アレルギー 2001;50(9. 10):981.

池田孔己, 金子篤, 山本雅浩, 佐々木博. オブア ルブミン感作マウスによる小青龍湯の抗原提示 細胞とCD4+T 細胞の相互作用に及ぼす影響. 和漢医藥學會. 2002;19:112.

Ikeda Y, Kaneko A, Yamamoto M, Ishige A, Sasaki H. Possible involvement of suppression of Th2 differentiation in the anti-allergic effect of Sho-seiryu-to in mice. Jpn J Pharmacol. 2002;90:328-36.      

Bae HH, Lee JE, Han YJ, Park YC. The inhibitory effects of Socheongryongtang (SCRT) on cytokine production and secretion of IgE in highly purified mouse B cells. Korean J Oreintal Int Med. 2003;24(2):249-59.

Nagai T, Arai Y, Emori M, Nunome S, Yabe T, Takeda T, et al. Anti-allergic activity of a Kampo (Japanese herbal) medicine "Sho-seiryu-to (Xiao- Qing-Long-Tang)" on airway inflammation in a mouse model. Int Immunopharmacol. 2004;4:1353 -65.      

Kubo M, Nishimura S, Matsuda H, Nakao K, Tahara E, Shintani T. Study on anti-allergic effects of Kampo medicines containing Ephedrae herba on dinitrofluorobenzene (DNFB)-induced triphasic skin reaction. J Trad Med. 2004;21(3): 147-53.

Jeong HJ, Hong Mc, Shin MK, Bae HS. Sochungyong-tang, traditional Korean medicine, suppresses Th2 lineage development. Korean J Oriental Physiology & Pathology. 2005;19(2): 380-8.

Kim KY, Lee JH, Kim YJ, Choi SY, Kim TH, Lyu YS, et al. Anti-allergic effects of Socheongryong-tang on RBL-2H3 mast cell and mice-medicated allergy model. Korean J Oriental Physiology & Pathology. 2007;21(5):1260-70.

Shimada T, Kondoh M, Motonaga C, Kitamura Y, Cheng L, Shi HB, et al. Enhancement of anti- allergic effects mediated by the Kampo medicine Shoseiryuto (Xiao-Qing-Long-Tang in Chinese) with lysed Enterococcus faecalis FK-23 in mice. Asian Pac J Allergy Immunol. 2010; 28:59-66.

池田勝久, 呉大正, 石垣元章, 須納瀬弘, 高坂知 節. 鼻腺細胞の刺激分泌応答に対する小青竜湯 の影響. The general meeting of Medical and Pharmaceutical Society for Wakan-yaku. 1993; 10:119.

坂口 理, 間瀬 明人, 飯塚 晃, 石毛 敦, 小松 靖弘, 岡田 稔, et al. 小青竜湯のモルモット実験的アレ ルギー性鼻炎に対する作用: Acoustic rhinometer を用いた評価. アレルギー. 1996;45(8. 9):886.

坂口 理, 池田 孔己, 飯塚 晃, 雨谷 栄, 小松 靖弘, 鵜飼 幸太郎, et al. 実験的鼻閉モデルに対する小 青竜湯の作用. The general meeting of Medical and Pharmaceutical Society for Wakan-yaku. 1998;15:106.

Yoshiki I, Atsushi K, Masahiro Y, Shuichi T, Masaki A. Effect of Sho-seiryu-to on the interaction between antigen presenting cells and CD4+ T cells in ovalbumin-sensitized mice. Kampo and Immuno-Allergy. 2004;17:10-20.

王树鹏, 郭晓東, 張麗艳, 朱辉, 关庆增. 小青龍湯及其加味方对变应性鼻炎大鼠IL-4和IL-4mRNA 表達的影響. 中藥藥理与臨床. 2006;22(1):7-9.

Das AK, Mizuguchi H, Kodama M, Dev S, Umehara H, Kitamura Y, et al. Sho-seiryu-to suppresses histamine signaling at the transcriptional level in TDI-sensitized nasal allergy model rats. Allergol Int. 2009;58:81-8.      

Wang WF, Tan XM, Liang SY, Hu YL, Zhang MM, Li T. Efficacy of Mahuang Fuzi Xixin de coction and Xiaoqinglong decoction on allergic rhinitis in guinea pigs. Chinese Journal of Experimental Traditional Medical Formulae. 2011;17(7):176-8.

Li JL, Chen BT. Experimental study of Xiaoqinglong on allergic rhinitis model. J Trop Med Feb. 2011;11(2):131-3.

Liu ZY. Xiaoqinglong decoction on allergic rhinitis in rats IL-4 and IFN- levels. Journal of Liaoning University of TCM. 2011;13(10):249-51

Okubo Y, Sekiguchi M. Effects of Sho-seiryu-to and Bakumondo-to on Human eosinophil viability and degranulation in vitro. Kampo Medicine. 1994;44(4):501-7.   

李儀奎, 吳健宇, 吳晓芬, 符胜光. 小青龍湯藥物血 清對致敏大鼠腹腔肥大细胞脱颗粒以及组织胺释 放的影響. 中國中西医结合雜志. 2000;20(1):40-2.

清原寛章, 宗形佳織, 永井隆之, 花輪壽彦, 山田 陽城. 漢方方剤の上気道粘膜免疫系に対する作 用の解析: 小青龍湯に対する十全大補湯, 補中益 気湯の比較. 和漢医藥學會. 2000;17:50.

俞仲毅, 汪鸿宇, 胡月娟, 李儀奎. 小青龍湯整体给 藥和含藥血清作用的比较研究. 中國中医藥科技. 2001;8(4):233-4.

Takayuki N, Haruki Y. Sho-seiryu-to (Xiao-Qing-Long-Tang) regulating respiratory- tract immunity through the intervention of the mucosal immune system. Kampo and Immuno-Allergy. 2001;15:47-55.

Seo YH, Bae HS, Thin MK, Hong MC. Effect of herbal extract on helper T cell activity. Korean J Oriental Physiology & Pathology. 2002;16(4): 693-700.

Ko E, Rho S, Lee EJ, Seo YH, Cho C, Lee Y, et al. Traditional Korean medicine (SCRT) modulate Th1/Th2 specific cytokine production in mice CD4+ T cell. J Ethnopharmacol. 2004;92: 121-8.      

KO E, Rho S, Cho C, Choi H, Ko S, Lee Y, et al. So-Cheong-Ryong-Tang, tradititional Korean medicine, suppresses Th2 lineage development. Biol Pharm Bull. 2004;27(5):739-43.      

永井隆之, 山田陽城. マウスのインフルエンザ 上気道感染に対する小青竜湯の効果. The general meeting of Medical and Pharmaceutical Society for Wakan-yaku. 1993;10:116.

Nagai T, Yamada H. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "Sho-seiryu-to" and its mode of action. Int J Immunopharmacol. 1994;16(8):605-13.      

永井隆之, 浦田政世, 松本司, 山田陽城. 小青竜 湯の抗インフルエンザウイルス活性: 加齢マウ ス及び亜型に対する効果. The general meeting of Medical and Pharmaceutical Society for Wakan-yaku.1995;12:131.

Nagai T, Urata M, Yamada H. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "Sho-Seiryu-To"-Effects on aged mice, against subtypes of a viruses and B virus, and therapeutic effect. Immunopharmacol Immunotoxicol. 1996;18(2):193-208.      

永井隆之, 松本司, 山田陽城. 小青竜湯の抗イ ンフルエンザウイルス活性: 腸管パイエル板細 胞に対する影響及び気道炎症モデルにおける抗 ウイルス活性. The general meeting of Medical and Pharmaceutical Society for Wakan-yaku. 1996;13:45.

Nagai T, Yamada H. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "Sho-Seiryu-To"—stimulation of mucosal immune system and effect on allergic pulmonary inflammation model mice. Immunopharmacol Immunotoxicol. 1998;20(2):267-81.      

Yamada H, Nagai T. In vivo antiinfluenza virus activity of Kampo medicine Sho-Seiryu-To through mucosal immune system. Methods Find Exp Clin Pharmacol. 1998;20(3):185.

永井隆之, 清原寛章, 山田陽城, 小青竜湯中の気 道粘膜免疫増強成分の解明: 経鼻接種インフルエ ンザワクチンに対する経口免疫増強成分. The general meeting of Medical and Pharmaceutical Society for Wakan-yaku. 1999;16:62.

Takeuchi Y, Nishimura Y, Yokomuro K, Kimura Y. Induction of experimental allergic conjunctivitis in guinea pigs passively sensitized with IgE antibody and clarification by light microscopic studies. Japanese Journal of Allergology. 1985;34(11):1021-7.

Lee CW, An WG. Single dose toxicity study of Socheongryong-tang in Sprague-Dawley rats. Korean J Oriental Physiology & Pathology. 2011;25(2):242-5.

Choi JH. Effects of Sochungryoung-tang on melanogenesis in B16 melanocytes. Jecheon (Chungbuk): Semyung Univ.; 2006.

Jung HJ, Kim IH. The microbiological studies on "Sochungyoung-tang". Kor J Pharmacog. 1983;14(3):119-24.

Ma J, Kim J, Jung K, Park K. Antimicrobial activity of Korean traditional prescription (Kumkue-Yoryak) and herb simplexes extracts to Vibrio parahemolyticus. Korean Journal of Oriental Medicine. 2000;6(1):107-16.

Kim BC. The effects of Sochungryongtang on obesity and antioxidant activities in Zucker rat. Gyeongju (Gyeongbuk): Dongguk Univ.; 2002.

Nakamichi N, Kosuge N. Effects of Sho-seiryu- to (Xiao-Qing-Long-Tang) on the corticoidogenesis in bovine adrenocortical cells. J Trad Med. 1999;16(4):163-7.

Konoshima T, Takasaki M, Kozuka M, Tokuda H. Anti-tumor promoting activities of Kampo prescriptions. II. Inhibitory effects of Shouseiryu-to on two-stage carcinogenesis of mouse skin tumors and mouse pulmonary tumors. Yakugaku Zasshi. 1994;114(4):248-56.

Akkoc T. Animal models of asthma. Marmara Pharmaceutical Journal. 2010;14:104-11.

Shin YS, Takeda K, Gelfand EW. Understanding asthma using animal models. Allergy Asthma Immunol Res. 2009;1(1):10-8.      

Filipovic M, Cekic S. The role of eosinophils in asthma. Medicine and Biology. 2001;8(1):6-10.

Sedgwick JB, Vrtis RF, Jansen KJ, Kita H, Bartemes K, Busse WW. Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin. J Allergy Clin Immunol. 2004; 114(3):568-74.      

Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet. 2002;360: 1715-21.      

Bentley AM, Menz G, Storz C, Robinson DS, Bradley B, Jeffery PK, et al. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma: Relationship to symptoms and bronchial responsiveness. Am J Respir Crit Care Med. 1992;146(2):500-6.     

Byers DE, Holtzman MJ. Alternatively activated macrophages and airway sisease. Chest. 2011;140(3):768-74.      

Durham SR, Till SJ, Corrigan CJ. T lymphocytes in asthma: Bronchial versus peripheral responses. J Allergy Clin Immunol. 2000;106(5):221-6.     

Freund V, Frossard N. Expression of nervegrowthfactor in the airways and its possible role in asthma. Progress in Brain Research. 2004; 146:335-46.

Bonini S, Lambiase A, Properzi F, Bresciani M, Laudiero MLB, Mancini MJ, et al. Nerve growth factor and asthma. Allergy. 2002;57(Suppl.72):13-5.

Höglund CO, Blay FD, Oster JP, Duvernelle C, Kassel O, Pauli G, et al. Nerve growth factor levels and localisation in human asthmatic bronchi. Eur Respir J. 2002;20:1110-6.      

Chung HL. Clinical significance of serum IgE. Korean Journal of Pediatrics. 2007;50(5):416-21.      

Balzar S, Strand M, Rhodes D, Wenzel SE. IgE expression pattern in lung: Relation to systemic IgE and asthma phenotypes. J Allergy Clin Immunol. 2007;119:855-62.      

Matsui EC, Sampson HA, Bahnson HT, Gruchalla RS, Pongracic JA, Teach SJ, et al. Allergen-specific IgE as a biomarker of exposure plus sensitization in inner-city adolescents with asthma. Allergy. 2010;65:1414-22.      

Naqvi M, Choudhry S, Tsai HJ, Thyne S, Navarro D, Nazario S, et al. Association between IgE levels and asthma severity among African American, Mexican, and Puerto Rican patients with asthma. J Allergy Clin Immunol. 2007; 120(1):137-43.      

Ahmad Al Obaidi AH, Mohamed Al Samarai AG, Yahya Al Samarai AK, Al Janabi JM. The predictive value of IgE as biomarker in asthma. J Asthma. 2008;45(8):654-63.      

Lee CH, Kim YS, Kang NI, Lee YM, Kim KJ, Chai OH, et al. IgG immune complex induces the recruitment of inflammatory cells into the airway and TNF-mediated late airway hyperresponsiveness via NF-B activation in mice. J Asthma. 2011;48(8):757-66.      

Ogurusu K, Takahashi K, Tada S, Soda R, Nanba K, Takata M, et al. Studies on IgG subclass antibodies in adult asthma. 1. Serum antigen specific IgG subclass antibodies in asthmatics with late asthmatic response. Allergy. 1991;40(5):506-15.

De José Gomez MI , De Dio JG, De Larramendi CH, García AJ, López MLV, Hortelano JG. IgG2 deficiency associated with recurrent pneumonia and asthma (review of an IgG subclass). Anales Espanoles De Pediatria. 1990;33,(3): 258-64.

Steinke JW, Borish L. Th2 cytokines and asthma Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir Res. 2001;2:66-70.      

Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol Rev. 2004 ;202:175-90.      

Tomasiak-Łozowska MM, Bodzenta-Łukaszyk A, Tomasiak M, Skiepko R, Ziętkowski Z. The role of interleukin 13 and interleukin 5 in asthma. Postepy Hig Med Dosw. 2010;64:146-55.

Lindén A. Role of interleukin-17 and the neutrophil in asthma. Int Arch Allergy Immunol. 2001;126(3):179-84.      

Park SJ, Lee YC. Interleukin-17 regulation: an attractive therapeutic approach for asthma. Respir Res. 2010;11:78.      

Bierbaum S, Nickel R, Zitnik S, Ahlert I, Lau S, Deichmann KA, et al. Confirmation of association of IL-15 with pediatric asthma and comparison of different controls. Allergy. 2006:61:576-80.      

Muro S, Taha R, Tsicopoulos A, Olivenstein R, Tonnel AB, Christodoulopoulos P, et al. Expression of IL-15 in inflammatory pulmonary diseases. J Allergy Clin Immunol. 2001;108(6): 970-5.      

Lama M, Chatterjee M, Nayak CR, Chaudhuri TK. Increased interleukin-4 and decreased interferon- levels in serum of children with asthma. Cytokine. 2011;55(3):335-8.      

Cohn L, Homer RJ, Niu N, Bottomly K. T helper 1 cells and interferon g regulate allergic airway inflammation and mucus production. J Exp Med. 1999;190(9):1309-17.      

Barnes PJ. Anti-inflammatory actions of gluco corticoids: molecular mechanisms. Clinical Science. 1998;94:557-72.

Verheggen MM, Adriaansen-Soeting PW, Berrevoets CA, van Hal PT, Brinkmann AO, Hoogsteden HC, et al. Glucocorticoid receptor expression in human bronchial epithelial cells: effects of smoking and COPD. Mediators Inflamm. 1998;7:275-81.      

Hall IP. Beta-2 adrenergic receptor dysfunction and polymorphism in asthma [Internet]. 2012;[1s creen]. Available at:URL:http://www.uptodate.c om/contents/beta-2-adrenergic-receptor-dysfunct ion-and-polymorphism-in-asthma. Accessed Ma y 2, 2012.

Thomsen M, Nordestgaard BG, Sethi AA, Tybjærg-Hansen A, Dahl M. 2-adrenergic receptor polymorphisms, asthma and COPD: two large populationbased studies. Eur Respir J. 2012;39:558-66.   

Scarpace PJ, Abrass IB. Glucocorticoid regulation of lung beta-adrenergic receptors. Drug Development Research. 1982;2(1):91-4.   

Miller GE, Chen E. Life stress and diminished expression of genes encoding glucocorticoid receptor and 2-adrenergic receptor in children with asthma. PNAS. 2006;103(14):5496-501.      

Chalmers GW, Little SA, Patel KR, Thomson NC. Endothelin-1-induced bronchoconstriction in asthma. Am J Respir Crit Med. 1997;156:382 -8.     

Bonow RO. New insights into the cardiac natriuretic peptides. Circulation 1996;93:1946-50.      

Cazzola M, Matera MG. B-type natriuretic peptide- Not only a biomarker. European Respiratory Disease. 2011;7(2):80-2.

Su YC, Rolph MS, Hansbro NG, Mackay CR, Sewell WA. Granulocyte-macrophage colony- stimulating factor Is required for bronchial eosinophilia in a murine model of allergic airway inflammation. J Immunol. 2008;180:2600-7.

Hoshi H, Ohno I, Honma M, Tanno Y, Yamauchi K, Tamura G, et al. IL-5, IL-8 and GM-CSF immunostaining of sputum cells in bronchial asthma and chronic bronchitis. Clin Exp Allergy. 1995;25(8):720-8.      

Guo FH, Comhair SAA, Zheng S, Dweik RA, Eissa NT, Thomassen MJ, et al. Molecular mechanisms of increased nitric oxide (NO) in asthma: Evidence for transcriptional and post-translational regulation of NO synthesis. J Immunol. 2000;164:5970-80.

Lelliott A, Nikkar-Esfahani A, Offer J, Orchard P, Roberts RE. The role of extracellular-signal regulate kinase (ERK) in the regulation of airway tone in porcine isolated peripheral bronchioles. Eur J Pharmacol. 2012;674(2-3):407-14.

Adachi T, Choudhury BK, Stafford S, Sur S, Alam R. The differential role of extracellular signal- regulated kinases and p38 mitogen-activated protein kinase in eosinophil functions. J Immunol 2000;165;2198-204.

Ge HY, Huang M, Yao X, Yin KS, Yang Y. Cyclin D1 and its association with airway remodeling in a murine model of asthma. Zhonghua Jie He He Hu Xi Za Zhi. 2006;29(9):607-11.

Inflammation and Innate Immunity in Asthma an d Allergies. 2012;[1screen]. Available at:URL:ht tp://www.medscape.org/viewarticle/503555. Acc essed May 3, 2012.

Pacheco-Martinez MM, Saucedo-Ramirez O, Navarro BDR, Rio-Chivardi JD, Cruz M, Perez-Figueroa GE, et al. Toll-like receptor 4 expression in obese asthmatic children with allergic inflammation. Bol Med Hosp Infant Mex. 2011; 68(4):257-61.

Machida K, Inoue H, Matsumoto K, Tsuda M, Fukuyama S, Koto H, et al. Activation of PI3K-Akt pathway mediates antiapoptotic effects of -adrenergic agonist in airway eosinophils. Am J Physiol Lung Cell Mol Physiol. 2005;288:860-7.   

Bouvry D, Planes C, Malbert-Colas L, Escabasse V, Clerici C. Hypoxia-induced cytoskeleton disruption in alveolar epithelial cells. Am J Respir Cell Mol Biol. 2006;35:519-27.